The first time Johnson & Johnson faced a lawsuit due to its talc-based baby powder causing cancer was way back in 1999. Since ...

With an array of new medicines and medical devices on display, global medical companies are looking to tap further into the ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

Both these factors can be tied in part to J&J’s strong presence in the consumer sector – but behind household name products is a ... s long and varied history. Johnson & Johnson was founded ...

Johnson & Johnson refused to add warning labels to its products. The company prioritized sales over consumer safety. By filing a J&J ovarian cancer lawsuit, women across the country may now be able to ...

As of November 07, 2024, Johnson & Johnson had a $380.1 billion market capitalization, putting it in the 100th percentile of companies in the Pharmaceuticals industry. Currently, Johnson & Johnson’s ...

Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib) as a monotherapy for the treatment ...

Johnson & Johnson’s Kenvue is to be its specialist Consumer Health division, separate from the company’s pharma and medical device operations. Indeed, Kenvue will apparently be guided by the ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

At its CIIE booth, the company also announced the China market launch of TECVAYLI®, an injection to treat relapsed or refractory multiple myeloma, which has the second highest incidence rate among all ...

Johnson & Johnson announced that the China National Medical Products Administration has approved Teclistamab Injection as a ...